Source Bioscience plc

Source Bioscience plc is a company in Nottingham, United Kingdom that has taken part in 6 EU-funded projects since 2009, receiving €1.9M in EU funding.

EU funding received€1.9M
EU projects6
As coordinator0
Running now0
First EU project2009
Latest project2013
CountryUnited Kingdom
EU registration (PIC)998644683
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Source Bioscience plc's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.9M · 6 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • REQUITEPartner

    Validating predictive models of radiotherapy toxicity to improve quality-of-life and reduce side-effects in cancer survivors

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €635ktheir share
  • RODAMPartner

    Type 2 diabetes and obesity among sub-Saharan African native and migrant populations: dissection of environment and endogenous predisposition

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €455ktheir share
  • HEM_IDPartner

    HEMatopoietic cell IDentity : genetic and epigenetic regulation in normal and malignant hematopoiesis

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €272ktheir share
  • DEM-CHILDPartner

    A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €147ktheir share
  • AFFINITYPROTEOMEPartner

    Advanced affinity tools and technologies for high throughput studies of the human proteome

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €177ktheir share
  • INTEGERPartner

    Integrated approaches to study gene regulation during cellular differentiation

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €208ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • automation
  • chromosomes
  • dementia
  • diabetes
  • drug discovery
  • epilepsy
  • gene therapy
  • history
  • homeostasis
  • human migrations
  • leukemia
  • lung cancer

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime